BioVie Inc. (BIVI) stock
BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$0.94−0.05 (-5.27%)
Close on Nov 18, 2026Market cap $7.11MP/E –Yield –
BioVie total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
BioVie's total debt was $2.97M at Sep 30, 2023. For fiscal 2023 it was $5.23M, down 56.9% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | $5.23M | -56.9% |
| FY2022 | Jun 30, 2022 | $12.14M | +19321.9% |
| FY2020 | Jun 30, 2020 | $62.50K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $2.97M | -76.7% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $5.23M | -56.9% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $7.41M | -36.3% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $13.26M | +19.3% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $12.73M | +20260.7% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $12.14M | +19321.9% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $11.62M | +18499.9% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $11.11M | +17677.9% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $62.50K | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $62.50K | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $62.50K | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $62.50K | – |
See a number that looks wrong?